Palvella Therapeutics (PVLA) Total Current Liabilities: 2013-2024
Historic Total Current Liabilities for Palvella Therapeutics (PVLA) over the last 10 years, with Sep 2024 value amounting to $4.3 million.
- Palvella Therapeutics' Total Current Liabilities fell 85.26% to $4.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.3 million, marking a year-over-year decrease of 85.26%. This contributed to the annual value of $2.4 million for FY2023, which is 93.55% down from last year.
- According to the latest figures from Q3 2024, Palvella Therapeutics' Total Current Liabilities is $4.3 million, which was down 32.97% from $6.3 million recorded in Q2 2024.
- Over the past 5 years, Palvella Therapeutics' Total Current Liabilities peaked at $50.6 million during Q4 2021, and registered a low of $2.4 million during Q4 2023.
- Over the past 3 years, Palvella Therapeutics' median Total Current Liabilities value was $33.5 million (recorded in 2022), while the average stood at $24.7 million.
- As far as peak fluctuations go, Palvella Therapeutics' Total Current Liabilities surged by 152.43% in 2021, and later slumped by 93.55% in 2023.
- Palvella Therapeutics' Total Current Liabilities (Quarterly) stood at $22.1 million in 2020, then skyrocketed by 128.32% to $50.6 million in 2021, then declined by 27.65% to $36.6 million in 2022, then plummeted by 93.55% to $2.4 million in 2023, then crashed by 85.26% to $4.3 million in 2024.
- Its Total Current Liabilities stands at $4.3 million for Q3 2024, versus $6.3 million for Q2 2024 and $7.5 million for Q1 2024.